-- （标题和第一段已更新股票走势信息。） Bloom Energy (BE) 的股价在周三的交易中上涨了近 24%，此前一天，该公司公布的第一季度调整后收益和营收均超出市场预期。 该公司周二晚间公布的第一季度调整后每股收益为 0.44 美元，高于去年同期的 0.03 美元。 FactSet 调查的分析师此前预期为 0.12 美元。 截至 3 月 31 日的三个月，营收为 7.511 亿美元，高于去年同期的 3.26 亿美元。 FactSet 调查的分析师此前预期为 5.399 亿美元。 该公司表示，已将 2026 年的调整后每股收益预期上调至 1.85 美元至 2.25 美元，营收预期上调至 34 亿美元至 38 亿美元。分析师此前的预期分别为 14.2 亿美元和 32.4 亿美元。
Price: $280.50, Change: $+54.13, Percent Change: +23.91%
Primaris Real Estate Investment Trust (PMZ-UN.TO) after trade Wednesday reported higher total rental revenue and profit for the first quarter and reaffirmed its 2026 outlook.The REIT earned $41.9 million, or $0.305 per unit, in the period, up from $31.2 million, or $0.257, a year ago. Corresponding FactSet figures were not available.Total rental revenue rose to $177.04 million from $150.2 million a year prior. FactSet expected sales of $180.8 million.Among other highlights, Primaris cited funds from operations per average diluted unit of $0.425 compared with $0.439 a year ago. FactSet projected FFO per share of $0.44."Our low leverage, low payout ratio model is a critical pillar to our strategy. We have significant liquidity with the full availability on our unsecured credit facility with no debt maturing in 2026, Chief Financial Officer Rags Davloor said."With strong liquidity, very low leverage, and a low payout ratio, we are well positioned to fund internal growth, enhance portfolio quality, and create long term value for our unitholders," Chief Executive Alex Avery added.The REIT said it is maintaining its full-year 2026 guidance.The REIT's units closed down $0.05 to $18.98 on the Toronto Stock Exchange.
Anatol Kreitzer, Chief Discovery Officer, on April 27, 2026, sold 45,422 shares in Maplight Therapeutics (MPLT) for $1,347,066. Following the Form 4 filing with the SEC, Kreitzer has control over a total of 211,190 voting common shares of the company, with 211,190 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1770069/000202123826000008/xslF345X05/form4-04292026_040429.xml
Jonathan Gillis, Chief Administrative and Accounting Officer and Principal Accounting Officer, on April 27, 2026, sold 69,835 shares in Maplight Therapeutics (MPLT) for $2,087,687. Following the Form 4 filing with the SEC, Gillis has control over a total of 181,219 voting common shares of the company, with 181,219 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1770069/000170995426000008/xslF345X05/form4-04292026_040431.xml